Remove 2030 Remove Packaging Remove Regulations
article thumbnail

Q&A: One scientist’s bold vision to make on-demand treatments routine for life-threatening rare genetic diseases

Broad Institute

It also needed to be delivered directly to the liver cells in his body, rather than to cells in a lab, and this was achieved by packaging the base editor in a lipid nanoparticle, a delivery system conceptually similar to the one used to deliver COVID vaccines to billions of people. He needed a personalized, one-of-a-kind therapy.

Treatment 133
article thumbnail

Baxter Releases Annual Corporate Responsibility Report Highlighting Global Impact

The Pharma Data

This comprehensive annual disclosure highlights progress against Baxter’s 2030 Corporate Responsibility Commitment and Goals—an ambitious framework structured around three guiding pillars: Empower Our Patients , Protect Our Planet , and Champion Our People and Communities. In 2024, the company reported a significant 13.5%

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Zebrafish Value Proposition for Cosmetic Testing

biobide

projected by the year 2030. Additional contributing factors include an increased awareness of fashion trends, innovations in the areas of hair coloring and skincare product formulations, and developments in the area of packaging. Such concerns have led to strict regulations regarding the formulation of cosmetic products.

article thumbnail

Analysis Chemical Thank You California publishes draft regulations for landmark plastic pollution reduction act

Agency IQ

California publishes draft regulations for landmark plastic pollution reduction act CalRecycle has launched the formal rulemaking process for Senate Bill 54, which will implement a sweeping plan to reduce plastic waste in the state by 2032. By 2028, the state will require the recycling of 30% of single-use packaging and food service ware.

article thumbnail

Regulatory Developments in Ophthalmology: Applying New FDA Guidance, Part One

The Premier Consulting Blog

billion in 2022 and is expected to grow approximately eight percent from 2023 to 2030 [1]. The FDA has determined that ophthalmic dispensers are now regulated as devices, and the drug and device together are regulated as a combination product. The global ophthalmic drugs market size was valued at $33.81

FDA 52
article thumbnail

Six Factors for Biotech Companies to Consider When Choosing Next-Generation Contract GMP/CMC Laboratories

PPD

Continued expansion of the biotech industry is occurring in parallel, with an estimated compound annual growth rate of 13.96% from 2023-2030. There has been an unprecedented expansion of different types of pharmaceutical therapies, as well as a change in the overall approach to health care.

article thumbnail

Article EMA Thank You EMA publishes first electronic Product Information as pilot progresses

Agency IQ

readability of package leaflet, patient engagement). Summary of Product Characteristics and Package Leaflet), recommending that sponsors and regulators “explore the use of electronic media” to provide product information “in the future”. The report recognized the potential for an electronic format for Product Information (i.e.,